Management of Cocaine-Induced Elevated Troponin

Initial Assessment and Risk Stratification

Patients presenting with cocaine-associated chest pain and elevated troponin should be evaluated for ST-segment changes on ECG, which guide management decisions 3, 4
Only 0.7% to 6% of patients with cocaine-associated chest pain actually have myocardial infarction (MI), making proper risk stratification essential 5
High-risk features include: ST-segment elevation or depression ≥1mm, elevated cardiac biomarkers, recurrent chest pain, or hemodynamic instability 5
Troponin I and T are more specific for myocardial injury than CK or CK-MB, which can be elevated due to increased motor activity, skeletal muscle injury, and rhabdomyolysis after cocaine use 1, 2

The American Heart Association recommends administering sublingual or IV nitroglycerin and calcium channel blockers as first-line therapy for patients with cocaine-induced elevated troponin, while avoiding beta-blockers due to risk of coronary vasoconstriction 1, 2, 3, 4, 5, 6
For patients with ST-segment elevation, the American College of Cardiology recommends administering sublingual or IV nitroglycerin and calcium channel blockers, and considering immediate coronary angiography if possible 1, 2, 4, 6

The American Heart Association recommends avoiding beta-blockers in the acute management of cocaine-induced cardiac toxicity as they can worsen coronary vasoconstriction through unopposed alpha-adrenergic activity 1, 2
If hypertension (>150 mmHg) or tachycardia (>100 bpm) persists despite vasodilator therapy, combined alpha/beta blockers may be considered, but only after administration of a vasodilator within the previous hour 4, 6

The American College of Cardiology recommends PCI over fibrinolytic therapy for cocaine-induced ST-elevation MI, as many patients have contraindications to fibrinolytics 1, 2, 5
If stents are deployed, bare-metal stents are generally preferred over drug-eluting stents due to shorter required duration of dual antiplatelet therapy 1, 2

Low to intermediate-risk patients can be safely managed in a chest pain observation unit for 9-12 hours with clinical and ECG monitoring plus repeat cardiac troponin measurements 5
This approach has been shown to reduce unnecessary admissions while maintaining safety 5

Cocaine can cause accelerated coronary atherosclerosis, coronary artery spasm, increased myocardial oxygen demand, and direct myocardial toxicity 2, 3
After cocaine use, CK and CK-MB may be elevated due to skeletal muscle activity without MI, making troponin the preferred biomarker 1, 2
The risk of in-stent thrombosis is substantial in cocaine users who receive stents but do not adhere to dual antiplatelet therapy 1, 2
Methamphetamine-induced cardiac toxicity should be managed similarly to cocaine-induced cardiac toxicity 1, 4, 6